Being considered a canonical cancer stem cell marker, PTPRZ1 has also been included in an integrative analysis of the heterogeneity present in GBM cancer stem cell populations by using a combination of flow cytometry and bulk and single-cell RNA-sequencing. The gene discussed is PTPRZ1; the disease is glioblastoma.